These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38479036)

  • 1. The efficacy and safety of aspirin-ticagrelor vs. aspirin-clopidogrel in ischemic stroke patients with cerebral artery stenting.
    Liu C; Liu M; Yang X; Luo T; Wang J; Li G
    Clin Neurol Neurosurg; 2024 Apr; 239():108229. PubMed ID: 38479036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Xie X; Johnston SC; Wang A; Xu Q; Bath PM; Pan Y; Li H; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Xu A; Jing J; Meng X; Wang Y
    JAMA Netw Open; 2023 Jun; 6(6):e2317037. PubMed ID: 37279000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ticagrelor Aspirin vs Clopidogrel Aspirin in
    Wang A; Meng X; Tian X; Zuo Y; Bath PM; Li H; Xie X; Jing J; Lin J; Wang Y; Zhao X; Liu L; Li Z; Jiang Y; Xu J; Wang F; Chen W; Cao M; Li J; Wang Y
    Neurology; 2023 Jan; 100(5):e497-e504. PubMed ID: 36535779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial.
    Pan Y; Meng X; Jin A; Johnston SC; Li H; Bath PM; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Yang H; Cheng J; Wang Z; Wang Y
    JAMA Neurol; 2022 Aug; 79(8):739-745. PubMed ID: 35727586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-Guided Dual Antiplatelet Therapy in Minor Stroke or Transient Ischemic Attack With a Single Small Subcortical Infarction.
    Liu H; Jing J; Wang A; Xu Q; Meng X; Li H; Li Z; Wang Y
    Neurology; 2023 Apr; 100(16):e1643-e1654. PubMed ID: 36697242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-Year Outcomes of Early Therapy With Ticagrelor vs Clopidogrel in
    Meng X; Wang A; Tian X; Johnston C; Li H; Bath PM; Xu Q; Zhang Y; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Wang Y
    Neurology; 2024 Feb; 102(3):e207809. PubMed ID: 38181311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Dose Clopidogrel versus Ticagrelor in CYP2C19 intermediate or poor metabolizers after percutaneous coronary intervention: A Meta-Analysis of Randomized Trials.
    Sheng XY; An HJ; He YY; Ye YF; Zhao JL; Li S
    J Clin Pharm Ther; 2022 Aug; 47(8):1112-1121. PubMed ID: 35396752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Ticagrelor versus Aspirin and Clopidogrel for Stroke Prevention in Patients with Vascular Disease: A Systematic Review and Meta-Analysis.
    Ma X; Li D; Liu S; Chen Y; Zhong P
    Eur Neurol; 2023; 86(4):229-241. PubMed ID: 37068471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet effect of ticagrelor with aspirin in acute minor stroke and transient ischemic attack stratified by
    Zhou M; Chen W; Pan Y; Lin Y; Meng X; Zhao X; Liu L; Lin J; Li H; Wang Y; Wang Y
    Aging (Albany NY); 2020 Dec; 13(3):3994-4006. PubMed ID: 33411687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial.
    Pereira NL; Farkouh ME; So D; Lennon R; Geller N; Mathew V; Bell M; Bae JH; Jeong MH; Chavez I; Gordon P; Abbott JD; Cagin C; Baudhuin L; Fu YP; Goodman SG; Hasan A; Iturriaga E; Lerman A; Sidhu M; Tanguay JF; Wang L; Weinshilboum R; Welsh R; Rosenberg Y; Bailey K; Rihal C
    JAMA; 2020 Aug; 324(8):761-771. PubMed ID: 32840598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of perioperative dual antiplatelet therapy with ticagrelor versus clopidogrel in carotid artery stenting.
    Marcaccio CL; Patel PB; Liang P; Rastogi V; Stangenberg L; Jim J; Schneider PA; Schermerhorn ML
    J Vasc Surg; 2022 Apr; 75(4):1293-1303.e8. PubMed ID: 34655685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ticagrelor-Aspirin Versus Clopidogrel-Aspirin Among
    Wang A; Xie X; Tian X; Johnston SC; Li H; Bath PM; Zuo Y; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Meng X; Wang Y
    Ann Intern Med; 2022 Nov; 175(11):1534-1542. PubMed ID: 36315949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empiric treatment with aspirin and ticagrelor is the most cost-effective strategy in patients with minor stroke or transient ischemic attack.
    Narasimhalu K; Chan J; Ang YK; De Silva DA; Tan KB
    Int J Stroke; 2024 Feb; 19(2):209-216. PubMed ID: 37679898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes and Sustainability of Using
    Lee CR; Sriramoju VB; Cervantes A; Howell LA; Varunok N; Madan S; Hamrick K; Polasek MJ; Lee JA; Clarke M; Cicci JD; Weck KE; Stouffer GA
    Circ Genom Precis Med; 2018 Apr; 11(4):e002069. PubMed ID: 29615454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ticagrelor versus Clopidogrel in
    Wang Y; Meng X; Wang A; Xie X; Pan Y; Johnston SC; Li H; Bath PM; Dong Q; Xu A; Jing J; Lin J; Niu S; Wang Y; Zhao X; Li Z; Jiang Y; Li W; Liu L; Xu J; Chang L; Wang L; Zhuang X; Zhao J; Feng Y; Man H; Li G; Wang B;
    N Engl J Med; 2021 Dec; 385(27):2520-2530. PubMed ID: 34708996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ticagrelor plus aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis.
    Li M; Yang Q; Shi J; Zhang X; Lin H; Ge F
    BMC Neurol; 2023 Aug; 23(1):303. PubMed ID: 37580668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ticagrelor versus clopidogrel on platelet reactivity measured by thrombelastography in patients with minor stroke or TIA.
    Yang Y; Chen W; Pan Y; Yan H; Meng X; Liu L; Wang Y; Wang Y
    Aging (Albany NY); 2020 Oct; 12(20):20085-20094. PubMed ID: 33065552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack.
    Wang Y; Zhao X; Lin J; Li H; Johnston SC; Lin Y; Pan Y; Liu L; Wang D; Wang C; Meng X; Xu J; Wang Y;
    JAMA; 2016 Jul; 316(1):70-8. PubMed ID: 27348249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of CYP2C19 genetic polymorphism on the pharmacodynamics and clinical outcomes for patients treated with ticagrelor: a systematic review with qualitative and quantitative meta-analysis.
    Xie Q; Xiang Q; Liu Z; Mu G; Zhou S; Zhang Z; Ma L; Gong Y; Jiang J; Cui Y
    BMC Cardiovasc Disord; 2022 Mar; 22(1):111. PubMed ID: 35300607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes and CYP2C19 Polymorphism Synergistically Impair the Antiplatelet Activity of Clopidogrel Compared With Ticagrelor in Percutaneous Coronary Intervention-treated Acute Coronary Syndrome Patients.
    Mohareb MW; AbdElghany M; Zaki HF; El-Abhar HS
    J Cardiovasc Pharmacol; 2020 Oct; 76(4):478-488. PubMed ID: 32675750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.